These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Results of radioiodine treatment of patients with immunogenic and non-immunogenic hyperthyroidism using different focal doses]. Moser E, Pickardt CR, Mann K, Engelhardt D, Kirsch CM, Knesewitsch P, Tatsch K, Kreisig T, Kurz C, Saller B. Nuklearmedizin; 1988 Jun; 27(3):98-104. PubMed ID: 3405782 [Abstract] [Full Text] [Related]
27. Gonadal radiation dose and its genetic significance in radioiodine therapy of hyperthyroidism. Robertson JS, Gorman CA. J Nucl Med; 1976 Sep; 17(9):826-35. PubMed ID: 956897 [Abstract] [Full Text] [Related]
28. [Experience with ambulatory radioiodine therapy of hyperthyroidism]. Róka R, Séra T, Valkusz Z, Julesz J, Csernay L, Pávics L. Orv Hetil; 1999 Jun 06; 140(23):1291-5. PubMed ID: 10412264 [Abstract] [Full Text] [Related]
29. Long-term carbimazole intake does not affect success rate of radioactive 131Iodine in treatment of Graves' hyperthyroidism. El Refaei SM, Shawkat W. Nucl Med Commun; 2008 Jul 06; 29(7):642-8. PubMed ID: 18528187 [Abstract] [Full Text] [Related]
30. Radioiodine treatment of hyperthyroidism at the Tikur Anbessa Hospital. Demena S, Abdulkadir J, Jorge Y. Ethiop Med J; 2001 Jan 06; 39(1):39-46. PubMed ID: 11338466 [Abstract] [Full Text] [Related]
33. Relevance of cause of hyperthyroidism in determining its management. Veneman TF, Weymer M, Tjabbes T, van Haeften TW. Neth J Med; 1989 Dec 06; 35(5-6):303-8. PubMed ID: 2635287 [Abstract] [Full Text] [Related]
34. Relapse of Graves' disease 23 years after treatment with radioactive iodine (131I). Hegele RA, Volpé R. J Clin Lab Immunol; 1985 Oct 06; 18(2):103-5. PubMed ID: 3841162 [Abstract] [Full Text] [Related]
37. Comparison of different thyroid committed doses in radioiodine therapy for Graves' hyperthyroidism. Grosso M, Traino A, Boni G, Banti E, Della Porta M, Manca G, Volterrani D, Chiacchio S, AlSharif A, Borsò E, Raschillà R, Di Martino F, Mariani G. Cancer Biother Radiopharm; 2005 Apr 06; 20(2):218-23. PubMed ID: 15869459 [Abstract] [Full Text] [Related]
38. Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy? Kobe C, Eschner W, Sudbrock F, Weber I, Marx K, Dietlein M, Schicha H. Nuklearmedizin; 2008 Apr 06; 47(1):13-7. PubMed ID: 18278207 [Abstract] [Full Text] [Related]
39. Calculation of the radioiodine dose for the treatment of Graves' hyperthyroidism: is more than seven-thousand rad target dose necessary? Bajnok L, Mezosi E, Nagy E, Szabo J, Sztojka I, Varga J, Galuska L, Leovey A. Thyroid; 1999 Sep 06; 9(9):865-9. PubMed ID: 10524564 [Abstract] [Full Text] [Related]
40. Radioiodine therapy in Graves' disease: is it possible to predict outcome before therapy? Isgoren S, Daglioz Gorur G, Demir H, Berk F. Nucl Med Commun; 2012 Aug 06; 33(8):859-63. PubMed ID: 22669051 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]